SCHEMBL1654006

SCHEMBL1654006

Cc1ccc(S(=O)(=O)Oc2c(C(=O)O)nc(N(C)S(=O)(=O)CCCCN)c3cccnc23)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
COMT P21964 5/20 0.37
TDP1 Q9NUW8 4/20 0.34
ALDH1A1 P00352 3/20 0.34
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
KDM4E B2RXH2 2/20 0.34
HTT P42858 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
LMNA P02545 1/20 0.34
MAPT P10636 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
PKM P14618 1/20 0.34
PTGDR2 Q9Y5Y4 1/20 0.32
GAA P10253 2/20 0.32
NPC1 O15118 1/20 0.32
GFER P55789 1/20 0.32
METAP2 P50579 1/20 0.31
METAP1 P53582 1/20 0.31
P2RY12 Q9H244 1/20 0.31
ESR1 P03372 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1654724 0.93 COMT (0.36) COMTTDP1ALDH1A1MEN1KMT2A
SCHEMBL11903869 0.85 CA1 (0.37) COMTALDH1A1KDM4EL3MBTL1
SCHEMBL1655563 0.84 COMT (0.34) COMTTDP1ALDH1A1MEN1KMT2A
SCHEMBL12780362 0.84 TDP1 (0.35) COMTTDP1ALDH1A1MEN1KMT2A
SCHEMBL10011877 0.83 COMT (0.34) COMTALDH1A1MEN1KMT2AKDM4E
SCHEMBL4762067 0.81 KMT2A (0.39) COMTTDP1ALDH1A1MEN1KMT2A
SCHEMBL1654648 0.79 CA1 (0.37) COMTALDH1A1KDM4EL3MBTL1
SCHEMBL7258128 0.79 TDP1 (0.45) COMTTDP1ALDH1A1MEN1KMT2A
SCHEMBL15371910 0.79 COMT (0.40) COMTTDP1ALDH1A1MEN1KMT2A
SCHEMBL1654647 0.79 CA1 (0.37) ALDH1A1KDM4EL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2675803-A1 MACROCYCLIC INTEGRASE INHIBITORS FOR USE IN THE TREATMENT OF FELINE IMMUNODEFICIENCY VIRUS Elanco Animal Health Ireland Limited (IE) 2013-12-25 EP disclosed
WO-2012112345-A1 MACROCYCLIC INTEGRASE INHIBITORS FOR USE IN THE TREATMENT OF FELINE IMMUNODEFICIENCY VIRUS ELANCO ANIMAL HEALTH IRELAND LIMITED (US) 2012-08-23 WO disclosed
EP-2488521-A1 MACROCYCLIC INTEGRASE INHIBITORS Elanco Animal Health Ireland Limited (IE) 2012-08-22 EP disclosed
WO-2011045330-A1 MACROCYCLIC INTEGRASE INHIBITORS TIBOTEC PHARMACEUTICALS (IE) 2011-04-21 WO disclosed